Green Valley Drugs Recalls Ketorolac Injection Due to Sterility Concerns
Green Valley Drugs is recalling 3,289 vials of Ketorolac Injection nationwide due to a lack of assurance of sterility in its compounding and quality control processes.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of sterility assurance in injectable medications, which poses a significant risk of serious injury or infection.
Plain-English summary
FVS Holdings, Inc. dba. Green Valley Drugs is recalling 3,289 vials of Ketorolac Injection, all strengths and presentations, including 10 mL multi-dose vials, 2 mL single-dose vials, and 1 mL single-dose vials. The affected products are prescription-only and were distributed nationwide.
The recall was initiated due to a lack of assurance of sterility in all sterile products compounded, repackaged, and distributed by the pharmacy. The FDA identified concerns associated with the facility's quality control processes that compromised the sterility of the products.
Patients and healthcare providers should stop using the affected vials immediately. The specific lot numbers and expiration dates for the recalled products are: Ketorolac 30 mg/mL 10 mL (Lot 20130327-B, Exp 6/27/2013) and Ketorolac 30 mg/mL 2 mL (Lot 20130326-B, Exp 6/26/2013; Lot 20130307-C, Exp 6/7/2013).
The recalled product
- Product
- Ketorolac Injection, all strengths and all presentations including a) Ketorolac 30 mg/mL 10 mL MDV, b) Ketorolac 30 mg/mL 2 mL SDV, c) Ketorolac 30 mg/mL 1 mL SDV, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Category
- Drug — Injectable
- Affected units
- 3,289
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: a) Ketorolac 30 mg/mL 10 mL: 20130327-B
- Exp 6/27/2013
- b) Ketorolac 30 mg/mL 2 mL: 20130326-B
- Exp 6/26/2013
- 20130307-C
- Exp 6/7/2013
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Alpha Lipoic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29